Natco Pharma’s shares end lower after the company reports a sharp decline in quarterly results. NDTV says the stock closes nearly 5% down, with investors reacting to weaker earnings and guidance signals. The company also declares a dividend, as reported by NDTV.
On the financials, both outlets describe a major contraction in profit and a steep decline in revenue compared with the same quarter last year. NDTV reports consolidated net profit falls 57% to about ₹207 crore, alongside revenue down 44.7% year-on-year to ₹735 crore. Business Line says Q1 net profit is down 57% to around ₹206 crore and revenue drops 43% to about ₹794 crore. The difference in revenue figures appears to reflect how the outlets present or classify revenue.
The overall context is that investors are focused on the year-on-year deterioration in profitability and sales momentum, following the release of Q1FY27 numbers. The reactions center on the scale of the declines highlighted across reporting, while the dividend announcement is cited as an offsetting factor.
